High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas

Cancer

Volumn 103, Issue 10, 2005, Pages 2163-2170

  Alexander, Dominik ^a   Jhala, Nirag ^a   Chatla, Chakrapani ^a   Steinhauer, Jon ^a   Funkhouser, Ellen ^a   Coffey, Christopher S ^a   Grizzle, William E ^a   Manne, Upender ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

African Americans; Caucasians; Colon carcinoma; High grade tumor differentiation

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CANCER SURVIVAL; CAUCASIAN; CHILD; COLON ADENOCARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; INFANT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; CHILD; CHILD, PRESCHOOL; COLONIC NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL RATE;

EID: 18044374947     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21021     Document Type: Article

References (54)

1. American Cancer Society. Cancer facts and figures. Atlanta: American Cancer Society, 2003:1-52.
2. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8-29.
3. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101:3-27.
4. Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer. 2000;88:2398-2424.
5. Ries LAG, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1975-2001. Bethesda, MD: National Cancer Institute. Available from URL: http://seer.cancer.gov/csr/1975_2001 [accessed June 2004].
6. Ciccone G, Prastaro C, Ivaldi C, et al. Access to hospital care, clinical stage and survival from colorectal cancer according to socio-economic status. Ann Oncol. 2000;11:1201-1204.
7. Jepson C, Kessler LG, Portnoy B, et al. Black-white differences in cancer prevention knowledge and behavior. Am J Public Health. 1991;81:501-504.
8. Mandelblatt J, Andrews H, Kao R, et al. The late-stage diagnosis of colorectal cancer: demographic and socioeconomic factors. Am J Public Health. 1996;86:1794-1797.
9. Rabeneck L, El-Serag HB, Davila JA, et al. Outcomes of colorectal cancer in the United States: no change in survival (1986-1997). Am J Gastroenterol 2003;98:471-477.
10. Clegg LX, Li FP, Hankey BF, et al. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) program population-based study. Arch Intern Med. 2002;162:1985-1993.
11. Merrill RM, Henson DE, Ries LA. Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon. Dis Colon Rectum. 1998;41:1097-1106.
12. Marcella S, Miller JE. Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status. J Clin Epidemiol. 2001;54:359-366.
13. Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995;87:1686-1693.
14. Rabeneck L, Souchek J, El-Serag HB. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am J Gastroenterol. 2003;98:1186-1192.
15. Wudel LJ Jr., Chapman WC, Shyr Y, et al. Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. Arch Surg. 2002;137:550-554; discussion 554-556.
16. Govindarajan R, Shah RV, Erkman LG, et al. Racial differences in the outcome of patients with colorectal carcinoma. Cancer. 2003;97:493-498.
17. Alexander D, Chatla C, Funkhouser E, et al. Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma. Cancer. 2004;101:66-76.
18. Willett C. Cancer of the lower gastrointestinal tract, atlas of clinical oncology. Hamilton, Ontario: B.C. Decker Inc., 2001.
19. Harris GJ, Senagore AJ, Lavery IC, et al. Factors affecting survival after palliative resection of colorectal carcinoma. Colorectal Dis. 2002;4:31-35.
20. Samowitz WS, Curtin K, Ma KN, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev. 2001;10:917-923.
21. Rabeneck L, Davila JA, Thompson M, et al. Surgical volume and long-term survival following surgery for colorectal cancer in the Veterans Affairs Health-Care System. Am J Gastroenterol. 2004;99:668-675.
22. Dominitz JA, Samsa GP, Landsman P, et al. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer. 1998;82:2312-2320.
23. Cooper GS, Yuan Z, Rimm AA. Racial disparity in the incidence and case-fatality of colorectal cancer: analysis of 329 United States counties. Cancer Epidemiol Biomarkers Prev. 1997;6:283-285.
24. Ries LA, Kosary CL, Hankey BF, et al. SEER cancer statistics review, 1973-1994. Bethesda, MD: National Cancer Institute, NIH, 1997.
25. Weaver P, Harrison B, Eskander G, et al. Colon cancer in African-Americans: a disease with a worsening prognosis. JAMA. 1991;83:133-136.
26. Myers MH. Survival from cancer by blacks and whites. Prog Clin Biol Res. 1981;53:151-165.
27. Nagel S, Chung EB, DeWitty RL Jr., et al. Colorectal cancer in young black patients. JAMA. 1988;80:37-40.
28. NCCN Aa, colon and rectal cancer treatment guidelines for patients. American Cancer Society (ACS) and the National Comprehensive Cancer Network (NCCN). Version III. Atlanta: American Cancer Society, 2003.
29. Green FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag, 2002.
30. World Health organization. International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization, 1990.
31. Grizzle WE, Manne U, Jhala N, et al. The molecular characterization of colorectal neoplasia in translational research. Arch Pathol Lab Med. 2001;125:91-98.
32. Grizzle WE, Manne U, Weiss HL, et al. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1). Int J Cancer. 2002;97:403-409.
33. Compton C, Fenoglio-Preiser CM, Pettigrew N, et al. American Joint Committee on Cancer prognostic factors consensus conference: colorectal working group. Cancer. 2000;88:1739-1757.
34. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:979-994.
35. Blenkinsopp WK, Stewart-Brown S, Blesovsky L, et al. Histopathology reporting in large bowel cancer. J Clin Pathol. 1981;34:509-513.
36. Fleiss J. Statistical methods for rates and proportions. New York: John Wiley & Sons, 1981.
37. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
38. Cox DR. Regression models and life tables. J Roy Stat Soc. 1972;34:187-220.
39. Allison P. Survival analysis using the SAS system: a practical guide. Gary, NC: SAS Institute Inc., 1995.
40. Kleinbaum D. Survival analysis: a self learning text. New York: Springer-Verlag, 1996.
41. Mostafa G, Matthews BD, Norton HJ, et al. Influence of demographics on colorectal cancer. Am Surg. 2004;70:259-264.
42. Chen VW, Fenoglio-Preiser CM, Wu XC, et al. Aggressiveness of colon carcinoma in blacks and whites. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biomarkers Prev. 1997;6:1087-1093.
43. Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349:247-257.
44. Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342:69-77.
45. Rigau V, Sebbagh N, Olschwang S, et al. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 [correction of hMLH6] immunostaining. Arch Pathol Lab Med. 2003;127:694-700.
46. Lim SB, Jeong SY, Lee MR, et al. Prognostic significance of microsatellite instability in sporadic colorectal cancer. Int J Colorectal Dis. 2004;19:533-537
47. Carethers JM, Smith EJ, Behling CA, et al. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology. 2004;126:394-401.
48. Nasca P PH. Fundamentals of cancer epidemiology. 1st ed. Gaithersburg, MD: Aspen, 2001.
49. Robbins SCR, Kumar V. Pathologic basis of disease. 5th ed. Philadelphia: W.B. Saunders Company, 1994.
50. Meyerhardt JA, Catalano PJ, Haller DG, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003;21:433-440.
51. Yancik R, Wesley MN, Ries LA, et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer. 1998;82:2123-2134.
52. Dignam JJ, Colangelo L, Tian W, et al. Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst. 1999;91:1933-1940.
53. McCollum AD, Catalano PJ, Haller DG, et al. Outcomes and toxicity in African-American and Caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst. 2002;94:1160-1167.
54. Dayal H, Polissar L, Yang CY, et al. Race, socioeconomic status, and other prognostic factors for survival from colorectal cancer. J Chron Dis. 1987;40:857-864.